PUBMED FOR HANDHELDS

Journal Abstract Search


292 related items for PubMed ID: 29569191

  • 1. Urinary CD80 excretion is a predictor of good outcome in children with primary nephrotic syndrome.
    Ling C, Liu X, Shen Y, Chen Z, Fan J, Jiang Y, Meng Q.
    Pediatr Nephrol; 2018 Jul; 33(7):1183-1187. PubMed ID: 29569191
    [Abstract] [Full Text] [Related]

  • 2. Urinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease.
    Ahmed HM, Ezzat DA, Doudar NA, Adel M.
    Iran J Kidney Dis; 2018 Mar; 12(2):107-111. PubMed ID: 29507273
    [Abstract] [Full Text] [Related]

  • 3. Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome.
    Mishra OP, Kumar R, Narayan G, Srivastava P, Abhinay A, Prasad R, Singh A, Batra VV.
    Pediatr Nephrol; 2017 Aug; 32(8):1355-1361. PubMed ID: 28210837
    [Abstract] [Full Text] [Related]

  • 4. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
    Alshami A, Roshan A, Catapang M, Jöbsis JJ, Kwok T, Polderman N, Sibley J, Sibley M, Mammen C, Matsell DG, Pediatric Nephrology Clinical Pathway Development Team.
    Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
    [Abstract] [Full Text] [Related]

  • 5. The utility of urinary CD80 as a diagnostic marker in patients with renal diseases.
    Minamikawa S, Nozu K, Maeta S, Yamamura T, Nakanishi K, Fujimura J, Horinouchi T, Nagano C, Sakakibara N, Nagase H, Shima H, Noda K, Ninchoji T, Kaito H, Iijima K.
    Sci Rep; 2018 Nov 23; 8(1):17322. PubMed ID: 30470792
    [Abstract] [Full Text] [Related]

  • 6. Urinary low-molecular-weight protein excretion in pediatric idiopathic nephrotic syndrome.
    Chehade H, Parvex P, Poncet A, Werner D, Mosig D, Cachat F, Girardin E.
    Pediatr Nephrol; 2013 Dec 23; 28(12):2299-306. PubMed ID: 23949592
    [Abstract] [Full Text] [Related]

  • 7. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance.
    Cara-Fuentes G, Wei C, Segarra A, Ishimoto T, Rivard C, Johnson RJ, Reiser J, Garin EH.
    Pediatr Nephrol; 2014 Aug 23; 29(8):1363-71. PubMed ID: 24263531
    [Abstract] [Full Text] [Related]

  • 8. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
    Bazzi C, Petrini C, Rizza V, Arrigo G, Napodano P, Paparella M, D'Amico G.
    Nephrol Dial Transplant; 2002 Nov 23; 17(11):1890-6. PubMed ID: 12401843
    [Abstract] [Full Text] [Related]

  • 9. Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis.
    Hamasaki Y, Yoshikawa N, Nakazato H, Sasaki S, Iijima K, Nakanishi K, Matsuyama T, Ishikura K, Ito S, Kaneko T, Honda M, for Japanese Study Group of Renal Disease in Children.
    Pediatr Nephrol; 2013 May 23; 28(5):765-71. PubMed ID: 23314441
    [Abstract] [Full Text] [Related]

  • 10. Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings.
    Pelletier JH, Kumar KR, Engen R, Bensimhon A, Varner JD, Rheault MN, Srivastava T, Straatmann C, Silva C, Davis TK, Wenderfer SE, Gibson K, Selewski D, Barcia J, Weng P, Licht C, Jawa N, Kallash M, Foreman JW, Wigfall DR, Chua AN, Chambers E, Hornik CP, Brewer ED, Nagaraj SK, Greenbaum LA, Gbadegesin RA.
    Pediatr Nephrol; 2018 Oct 23; 33(10):1773-1780. PubMed ID: 29982878
    [Abstract] [Full Text] [Related]

  • 11. Patients with primary focal segmental glomerulosclerosis with detectable urinary CD80 are more similar to patients with minimal change disease in clinicopathological features.
    Gong X, Huang J, Zhang Y, Wang F, Wang X, Meng L, Cheng X, Liu G, Cui Z, Zhao M.
    Ren Fail; 2023 Oct 23; 45(2):2279642. PubMed ID: 37942512
    [Abstract] [Full Text] [Related]

  • 12. [Minimal change disease and focal segmental glomerulosclerosis].
    Müller-Deile J, Schenk H, Schiffer M.
    Internist (Berl); 2019 May 23; 60(5):450-457. PubMed ID: 30887070
    [Abstract] [Full Text] [Related]

  • 13. Correlation of fractional excretion of magnesium with steroid responsiveness in children with nephrotic syndrome.
    Rumana J, Hanif M, Muinuddin G, Maruf-Ul-Quader M.
    Saudi J Kidney Dis Transpl; 2014 Jul 23; 25(4):830-6. PubMed ID: 24969196
    [Abstract] [Full Text] [Related]

  • 14. Rationale and design of the Japanese Biomarkers in Nephrotic Syndrome (J-MARINE) study.
    Kurasawa S, Kato S, Ozeki T, Akiyama S, Ishimoto T, Mizuno M, Tsuboi N, Kato N, Kosugi T, Maruyama S, J-MARINE collaborators.
    Clin Exp Nephrol; 2024 May 23; 28(5):431-439. PubMed ID: 38267800
    [Abstract] [Full Text] [Related]

  • 15. Urinary CD80 levels as a diagnostic biomarker of minimal change disease.
    Ling C, Liu X, Shen Y, Chen Z, Fan J, Jiang Y, Meng Q.
    Pediatr Nephrol; 2015 Feb 23; 30(2):309-16. PubMed ID: 25142334
    [Abstract] [Full Text] [Related]

  • 16. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.
    Woroniecki RP, Shatat IF, Supe K, Du Z, Kaskel FJ.
    Am J Nephrol; 2008 Feb 23; 28(1):83-90. PubMed ID: 17914249
    [Abstract] [Full Text] [Related]

  • 17. The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome.
    Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I, Koide H.
    Am J Nephrol; 2000 Feb 23; 20(3):175-9. PubMed ID: 10878397
    [Abstract] [Full Text] [Related]

  • 18. Urinary fibrinogen and renal tubulointerstitial fibrinogen deposition: Discriminating between primary FSGS and minimal change disease.
    Wang Y, Zheng C, Xu F, Liu Z.
    Biochem Biophys Res Commun; 2016 Sep 23; 478(3):1147-52. PubMed ID: 27539323
    [Abstract] [Full Text] [Related]

  • 19. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.
    Garin EH, Mu W, Arthur JM, Rivard CJ, Araya CE, Shimada M, Johnson RJ.
    Kidney Int; 2010 Aug 23; 78(3):296-302. PubMed ID: 20485332
    [Abstract] [Full Text] [Related]

  • 20. Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis.
    Garin EH, Reiser J, Cara-Fuentes G, Wei C, Matar D, Wang H, Alachkar N, Johnson RJ.
    Pediatr Nephrol; 2015 Mar 23; 30(3):469-77. PubMed ID: 25239302
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.